BNP Paribas Financial Markets
TPST icon

BNP Paribas Financial Markets’s Tempest Therapeutics TPST Stock Holding History

BNP Paribas Financial Markets’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3 Hold
3
– – ﹤0.01% 5890
2026
Q1 		$5 Hold
3
– – ﹤0.01% 5781
2025
Q4 		$9 Hold
3
– – ﹤0.01% 5696
2025
Q3 		$31 Hold
3
– – ﹤0.01% 5487
2025
Q2 		$20 Sell
3
-1
-25% -$7 ﹤0.01% 5392
2025
Q1 		$35 Hold
4
– – ﹤0.01% 5304
2024
Q4 		$40 Buy
+4
New +$52 ﹤0.01% 5325
2022
Q4 		– Sell
-6
Closed -$127 – 4603
2022
Q3 		$127 Buy
+6
New +$178 ﹤0.01% 4636
2021
Q2 		– Sell
-6
Closed -$1.32K – 4107
2021
Q1 		$1.32K Hold
6
– – ﹤0.01% 3913
2020
Q4 		$2.35K Sell
6
-7
-54% -$2.42K ﹤0.01% 3995
2020
Q3 		$4.26K Sell
13
-203
-94% -$68.8K ﹤0.01% 4023
2020
Q2 		$74.2K Buy
216
+199
+1,171% +$79.4K ﹤0.01% 2883
2020
Q1 		$17.1K Buy
17
+10
+143% +$14.6K ﹤0.01% 3940
2019
Q4 		$8.76K Buy
7
+5
+250% +$7.05K ﹤0.01% 4143
2019
Q3 		$3.3K Buy
+2
New +$3.23K ﹤0.01% 4318
2019
Q2 		– Hold
0
– – – 4447
2017
Q2 		– Hold
0
– -$933 – 4338
2017
Q1 		– Sell
-1
Closed -$4.66K – 3712
2016
Q4 		$3.06K Hold
1
– – ﹤0.01% 3844
2016
Q3 		$16.7K Buy
+1
New +$18.1K ﹤0.01% 2991
2016
Q2 		– Hold
0
– – – 3142
2016
Q1 		– Sell
-2
Closed -$42.3K – 2465
2015
Q4 		$51.7K Hold
2
– – ﹤0.01% 2794
2015
Q3 		$41.8K Buy
2
+1
+100% +$67.3K ﹤0.01% 2998
2015
Q2 		$56.5K Buy
+1
New +$91.6K ﹤0.01% 2426
2015
Q1 		– Hold
0
– – – 2676
2014
Q4 		– Hold
0
– -$19K – 3093
2014
Q3 		– Hold
0
– – – 3205
2014
Q2 		– Hold
0
– – – 2711
2014
Q1 		– Hold
0
– – – 2526
2013
Q4 		– Hold
0
– – – 3172

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BNP Paribas Financial Markets's TPST Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Tempest Therapeutics (TPST) position steady in Q2 2026 at 3 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #5890.

BNP Paribas Financial Markets first reported a position in TPST in Q2 2015 and has held it in 20 quarters since. The position peaked at $74.2K in Q2 2020. 13 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

  • BNP Paribas Financial Markets held 3 shares of Tempest Therapeutics worth $3 as of Q2 2026.
  • BNP Paribas Financial Markets left its Tempest Therapeutics share count unchanged in Q2 2026.
  • Tempest Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5890 holding.
  • BNP Paribas Financial Markets first reported a position in Tempest Therapeutics in Q2 2015 and has held it in 20 quarters since.
  • BNP Paribas Financial Markets's Tempest Therapeutics position peaked at $74.2K in Q2 2020.
  • 13 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.